Embla Systems LLC Market Share Analysis

Publisher Name :
Date: 12-Dec-2012
No. of pages: 27
Inquire Before Buying

Embla Systems LLC Market Share Analysis

Summary

GlobalData’s new report, “Embla Systems LLC Market Share Analysis” provides in-depth information on Embla Systems LLC’s market position in the sleep apnea diagnostic systems market. The report also provides data and information on the overall competitive landscape within the sleep apnea diagnostic systems market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the sleep apnea diagnostic systems market.
- Embla Systems LLC’s company shares (in Revenues) information for all the key countries the company has presence in -Brazil, Italy, Spain, United Kingdom, Germany, China, Japan, India, Australia, United States and Canada.
- Embla Systems LLC’s company shares (in Revenues) information for the sleep apnea diagnostic systems market.
- All the key data-points are for 2011 and cover all the key regions -Europe, Asia-Pacific, North America, South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Embla Systems LLC’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Embla Systems LLC’s market positions.

Embla Systems LLC Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
3 Definitions of Markets/Categories Covered 6
3.1 Anesthesia and Respiratory Devices 6
3.1.1 Sleep Apnea Diagnostic Systems 6
4 Company Snapshot 7
4.1 Key Information 7
4.2 Company Overview 7
4.3 Major Products and Services 8
4.3.1 Overview 8
5 Competitors 9
6 Competitive Landscape 10
6.1 Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), Global, Market Share (%), 2011 10
6.2 Embla Systems LLC, Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), by Region, Market Share (2011) 12
6.3 Embla Systems LLC, Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), by Country, Market Share (2011) 13
7 Key Employees 15
8 Locations And Subsidiaries 15
8.1 Head Office 15
9 Financial Deals Landscape 16
9.1 Embla Systems LLC, Deals Volume Summary, 2006 to YTD 2012 16
10 Embla Systems LLC Detailed Deal Summary 18
10.1 Asset Purchase 18
10.1.1 Covidien Sells Sleep Diagnostics Products To Embla Systems 18
10.2 Partnerships 19
10.2.1 Embla Systems Enters Into Collaboration With Beth Israel Deaconess 19
10.3 Acquisition 20
10.3.1 Natus Medical Acquires Embla Systems For $16.1 Million 20
11 Recent Developments 21
11.1 Other Significant Developments 21
11.1.1 Apr 02, 2010: Premier Awards New Contracts For Polysomnography, Neurological Equipment And Accessories 21
12 Appendix 22
12.1 Research Methodology 23
12.2 Secondary Research 23
12.3 Primary Research 24
12.4 Models 24
12.5 Forecasts 24
12.6 Expert Panels 25
12.7 GlobalData Consulting 25
12.8 Currency Conversion 26
12.9 Contact Us 27
12.10 Disclaimer 27

1.1 List of Tables
Table 1: Embla Systems LLC, Key Information, 2011 7
Table 2: Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), Global, Company Share by Revenue ($m), 2011 11
Table 3: Embla Systems LLC, Anesthesia and Respiratory Devices, Sleep Apnea Diagnostic Systems, Global, Revenue ($m) and Market Share (%), 2011 12
Table 4: Embla Systems LLC, Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), by Country, Revenue ($m) and Market Share (%), 2011 14
Table 5: Embla Systems LLC, Key Employees 15
Table 6: Embla Systems LLC, Deals Volume Summary, 2006 to YTD 2012 16
Table 7: Embla Systems LLC, Deals Summary, 2006 to YTD 2012 17
Table 8: Covidien Sells Sleep Diagnostics Products To Embla Systems 18
Table 9: Embla Systems Enters Into Collaboration With Beth Israel Deaconess 19
Table 10: Natus Medical Acquires Embla Systems For $16.1 Million 20
Table 11: USD to Local Currency, Average Exchange Rate, 2011 26

1.2 List of Figures
Figure 1: Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), Global, Market Share (%), 2011 10
Figure 2: Embla Systems LLC, Anesthesia and Respiratory Devices, Sleep Apnea Diagnostic Systems, Global, Market Share (%), 2011 12
Figure 3: Embla Systems LLC, Anesthesia and Respiratory Devices (Sleep Apnea Diagnostic Systems), by Country, Market Share (%), 2011 13
Figure 4: Embla Systems LLC, Deals Volume Summary, 2006 to YTD 2012 16
  • Global Cystic Fibrosis Market Propelled by Technological Advancement
    With increasing prevalence of cystic fibrosis and its growing awareness among people, the global market for cystic fibrosis is expected to grow at a steady pace. Cystic fibrosis is a genetic condition where the lungs and digestive system becomes clogged with excess mucus. This condition is more common among Caucasian population than people of Asian [...]
  • Bright Prospects Ahead for the SONAR Systems and Technology Market
    With advancement of technology, the global SONAR systems and technology market is increasing at a rapid pace. SONAR which is an acronym for SOund Navigation And Ranging is a technique that uses sound propagation to navigate and communicate with objects on or under the surface of the water, such as other vessels. In 2014, the [...]
  • Increase in Surgical Procedures Propelling the Anesthesia Drugs Market
    With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the [...]
  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • To bring in Photography to the Real World Visual Supply Co Acquires Artifact Uprising
  • Visual Supply Co, VSCO has brought a Denver-based startup, Artifact Uprising, which is focused on bringing photographers’ work from the digital hubs on regular basis by modern creatives to the real world as prints and tangible books. Artifact Uprising is …

  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Peripheral Neuropathy (Sensory Neuropathy) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015', provides an overview of the Peripheral Neuropathy (Sensory Neuropathy)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along wit......
  • Polycystic Ovarian Syndrome – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Polycystic Ovarian Syndrome - Pipeline Review, H1 2015', provides an overview of the Polycystic Ovarian Syndrome's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press......
  • Dyslipidemia – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Dyslipidemia - Pipeline Review, H1 2015', provides an overview of the Dyslipidemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dyslipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players invo......
  • Growth Hormone Deficiency – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Growth Hormone Deficiency - Pipeline Review, H1 2015', provides an overview of the Growth Hormone Deficiency's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Growth Hormone Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press relea......
  • Acute Heart Failure – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Acute Heart Failure - Pipeline Review, H1 2015', provides an overview of the Acute Heart Failure's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also revie......
  • Endometriosis – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Endometriosis - Pipeline Review, H1 2015', provides an overview of the Endometriosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players inv......
  • Proliferative Vitreoretinopathy (PVR) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015', provides an overview of the Proliferative Vitreoretinopathy (PVR)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Proliferative Vitreoretinopathy (PVR), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest update......
  • Diabetic Peripheral Neuropathy – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015', provides an overview of the Diabetic Peripheral Neuropathy's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ......
  • Kaposi’s Sarcoma – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Kaposi's Sarcoma - Pipeline Review, H1 2015', provides an overview of the Kaposi's Sarcoma's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Kaposi's Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs